Citations

Clear

3138 citation(s) found for "Smith, AM".

A Behavioral Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
Greenaway, Melanie C., Hanna, Sherrie , Lepore, Susan , Smith, Glenn E.

Mayo Clinic

American Journal of Alzheimer's Disease & Other Dementias® | October 27, 2008 | Volume: 23 | Issue: 5 | Pages: 451-461

10.1177/1533317508320352 | PMID 18955724 Get It

Individuals with amnestic mild cognitive impairment (MCI) currently have few treatment options for combating their memory loss. The Memory Support System (MSS) is a calendar and organization system with accompanying 6-week curriculum designed for individuals with progressive memory impairment. Ability to learn the MSS and its utility were assessed in 20 participants. Participants were significantly more likely to successfully use the calendar system after training. Ninety-five percent were compliant with the MSS at training completion, and 89% continued to be compliant at follow-up. Outcome measures revealed a medium effect size for improvement in functional ability. Subjects further reported improved independence, self-confidence, and mood. This initial examination of the MSS suggests that with appropriate training, individuals with amnestic MCI can and will use a memory notebook system to help compensate for memory loss. These results are encouraging that the MSS may help with the symptoms of memory decline in MCI.
Pilot Study of Transesophageal Endoscopic Surgery: NOTES Esophagomyotomy, Vagotomy, Lymphadenectomy
Woodward, Timothy A., McCluskey, David, Wallace, Michael B. , Raimondo, Massimo , Mannone, John, Smith, C. Daniel , Wallace, Michael B

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | September 26, 2008 | Volume: 18 | Issue: 5 | Pages: 743-745

10.1089/lap.2008.0226 | PMID 18803520 Get It

Reply to “Quality of life after tonsillectomy in children with recurrent tonsillitis”
Goldstein, Nira A. , Stewart, Michael G. , Witsell, David L., Hannley, Maureen, Weaver, Edward M. , Yueh, Bevan , Smith, Timothy L. , Orvidas, Laura J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | September 25, 2008 | Volume: 139 | Issue: 4 | Pages: 608-609

10.1016/j.otohns.2008.07.012 Get It

Improving Diabetes Care in Practice
Peterson, Kevin , O’Connor, Patrick J. , Nyman, John A. , Prineas, Ronald J. , Smith, Steven A., Arneson, Thomas J., Corbett, Victor A., Weinhandl, Joyce C., Lange, Carol J., Hannan, Peter J., Radosevich, David M. , Corbett, V, Peterson, Kevin J.

Mayo Clinic

Diabetes Care | September 22, 2008 | Volume: 31 | Issue: 12 | Pages: 2238-2243

10.2337/dc08-2034 | PMID 18809622 Get It

OBJECTIVE—The purpose of this study was to determine whether implementation of a multicomponent organizational intervention can produce significant change in diabetes care and outcomes in community primary care practices. RESEARCH DESIGN AND METHODS—This was a group-randomized, controlled clinical trial evaluating the practical effectiveness of a multicomponent intervention (TRANSLATE) in 24 practices. The intervention included implementation of an electronic diabetes registry, visit reminders, and patient-specific physician alerts. A site coordinator facilitated previsit planning and a monthly review of performance with a local physician champion. The principle outcomes were the percentage of patients achieving target values for the composite of systolic blood pressure (SBP) <130 mmHg, LDL cholesterol <100 mg/dl, and A1C <7.0% at baseline and 12 months. Six process measures were also followed. RESULTS—Over 24 months, 69,965 visits from 8,405 adult patients with type 2 diabetes were recorded from 238 health care providers in 24 practices from 17 health systems. Diabetes process measures increased significantly more in intervention than in control practices, giving net increases as follows: foot examinations 35.0% (P < 0.0.001); annual eye examinations 25.9% (P < 0.001); renal testing 28.5% (P < 0.001); A1C testing 8.1%(P < 0.001); blood pressure monitoring 3.5% (P = 0.05); and LDL testing 8.6% (P < 0.001). Mean A1C adjusted for age, sex, and comorbidity decreased significantly in intervention practices (P < 0.02). At 12 months, intervention practices had significantly greater improvement in achieving recommended clinical values for SBP, A1C, and LDL than control clinics (P = 0.002). CONCLUSIONS—Introduction of a multicomponent organizational intervention in the primary care setting significantly increases the percentage of type 2 diabetic patients achieving recommended clinical outcomes.
BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf Proteins
Friday, Bret B., Yu, Chunrong, Dy, Grace K. , Smith, Paul D. , Thibodeau, Stephen N. , Adjei, Alex A. , Wang, Liang

Mayo Clinic

Cancer Research | August 1, 2008 | Volume: 68 | Issue: 15 | Pages: 6145-6153

10.1158/0008-5472.can-08-1430 | PMID 18676837 Get It

Abstract AZD6244 (ARRY 142886) is a potent and selective mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor currently in early clinical trials. We examined the activity of AZD6244 in a panel of non–small cell lung cancer and a panel of cell lines representing many cancer types using in vitro growth assays. AZD6244 induced G0-G1 cell cycle arrest in sensitive cell lines that primarily included cells containing the BRAF V600E mutation. In these cells, G0-G1 arrest is accompanied by the up-regulation of the cell cycle inhibitors p21WAF1 and p27Kip1 and down-regulation of cyclin D1. In the majority of cell lines tested, including those with K-ras or non-V600E BRAF mutations, AZD6244 induced the accumulation of phospho-MEK, an effect not observed in the most sensitive BRAF V600E-containing cells. Accumulation of phospho-MEK in non–V600E-containing cell lines is due to abrogation of negative feedback pathways. BRAF V600E disrupts negative feedback signaling, which results in enhanced baseline phospho-MEK expression. Exogenous expression of BRAF V600E disrupts feedback inhibition but does not sensitize cells to AZD6244. Specific suppression of endogenous BRAF V600E does not confer resistance to AZD6244 but enhances sensitivity to AZD6244. Thus, our findings show that BRAF V600E marks cells with an in vitro requirement for MAPK signaling to support proliferation. These cells are exquisitely sensitive to AZD6244 (IC50, <100 nmol/L), have high baseline levels of phospho-MEK, and lack feedback inhibition between ERK and Raf. These data suggest an approach to identifying cells that may be sensitive to AZD6244 and other MEK inhibitors. [Cancer Res 2008;68(15):6145–53]
P2‐221: Daytime hypersomnolence on the multiple sleep latency test in patients with dementia with Lewy bodies
Silber, Michael H. , Lin, Siong-Chi, Tippmann‐Peikert, Maja, Ferman, Tanis J. , Boeve, Bradley F. , Smith, Glenn E.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2008.05.1296 Get It

P2‐219: Polysomnographic evidence of sleep fragmentation and poor sleep efficiency in dementia with Lewy bodies
Silber, Michael H. , Lin, Siong-Chi, Tippmann‐Peikert, Maja, Boeve, Bradley F. , Ferman, Tanis J. , Smith, Glenn E.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2008.05.1294 Get It

IC‐P2‐108: MRI and 1H MRS markers are complementary in predicting risk of future dementia in mild cognitive impairment
Weigand, Stephen D. , Shiung, Maria M., Whitwell, Jennifer L. , Ivnik, Robert J., O’Brien, Peter C. , Petersen, Ronald C. , Kantarci, Kejal , Negash, Selam , Smith, Glenn E. , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2008.05.101 Get It

P4‐136: Parkinsonism is associated with probable REM sleep behavior disorder in cognitively normal elderly subjects: The Mayo Clinic Study of Aging
Mihci, Nur E., Molano, Jennifer Rose V. , Roberts, Rosebud O., Knopman, David S. , Tangalos, Eric G., Ivnik, Robert J., Cha, Ruth, Pankratz, Shane, Silber, Michael H. , Petersen, Ronald C. , Boeve, Bradley F. , Geda, Yonas E. , Smith, Glenn E. , Ferman, Tanis J.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_22 | Pages: No page available

10.1016/j.jalz.2008.05.2202 Get It